Company news
Citius Oncology, Inc. news in 2024
Citius Oncology, Inc.'s news releases, calls and decks from 2024, newest first.
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
December 26, 2024
Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
December 26, 2024
Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 4, 2024
Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.
August 11, 2024
TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update
August 8, 2024
TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals
August 4, 2024
Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.
August 4, 2024
TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal
January 9, 2024